Dazucorilant

DRUG3 trials

Sponsors

Corcept Therapeutics

Conditions

Amyotrophic Lateral SclerosisHealthy AdultsHepatic Impairment

Phase 1

Impact of Itraconazole on the Pharmacokinetics and Safety of Dazucorilant in Healthy, Adult Participants

CompletedNCT06495944

Corcept TherapeuticsHealthy Adults

Start: 2024-05-31End: 2024-08-02Updated: 2025-07-01

Effects of Hepatic Impairment on the Pharmacokinetics of Dazucorilant

CompletedNCT06928779

Corcept TherapeuticsHepatic Impairment

Start: 2024-10-08End: 2024-12-09Updated: 2025-04-15

Phase 2

Dazucorilant in Patients With Amyotrophic Lateral Sclerosis

RecruitingNCT05407324

Corcept TherapeuticsAmyotrophic Lateral Sclerosis

Start: 2022-11-15End: 2027-11-01Target: 279Updated: 2026-06-16